Clayton Jackson, M.D. Titles and Appointments Assistant Professor School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Clayton Jackson, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology & Oncology. Originally from Alpharetta, Georgia, Dr. Jackson spent his formative years in South Florida. He holds a bachelor's degree in neuroscience, and minored in chemistry at the University of Miami, where he graduated cum laude. He earned his medical degree at Georgia Regents University Medical College of Georgia and received internal medicine residency training at Atrium Health Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. He then completed additional training in advanced cellular therapy and bone marrow transplant through a fellowship at Stanford Medical Center in California. Certified by the American Board of Internal Medicine in hematology and medical oncology, Dr. Jackson joined the UT Southwestern faculty in 2023. Dr. Jackson's research interests include acute leukemias, allogeneic transplants, and adoptive cell therapies. His investigations have been published in peer-reviewed academic journals and he has delivered presentations at scientific conferences. In his free time, Dr. Jackson enjoys the quiet life with his family and two dogs or watching the Miami Hurricanes play football. Education Medical School Medical College of Georgia at Augusta University (2016) Internship Wake Forest Baptist Medical Center (2017) Residency Wake Forest School of Medicine (2019), Internal Medicine Fellowship Wake Forest Baptist Health (2022), Hematology Oncology Fellowship Stanford University Medical Center (2023), Bone Marrow Transplant Publications Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia Mort JF, Brighton D, DiBenedetto S, Wells L, Clark SM, Reid J, Patel I, Jackson C, Yelvington B, Miller R, Perciavalle M, Walsh K, Wolfe H, Locke SC, Zeidner JF, Duong VH, Reed DR, Dholaria B, LeBlanc TW, Keng M, Horton B, El Chaer F European Journal of Haematology 2025 Mar 114 481-494 A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia Srinagesh H, Jackson C, Shiraz P, Jeyakumar N, Hamilton M, Egeler E, Mavroukakis S, Kuo A, Cancilla J, Sahaf B, Agarwal N, Kanegai A, Kramer AM, Arai S, Bharadwaj S, Dahiya S, Hosoya H, Johnston L, Kennedy V, Liedtke M, Lowsky R, Mikkilineni L, Negrin R, Rezvani A, Sidana S, Shizuru J, Smith M, Weng WK, Feldman S, Frank MJ, Lee Z, Tagliaferri M, Marcondes AM, Miklos D, Mackall C, Muffly L Blood 2024 Oct 144 1689-1698 Eosinophilia and the Hypereosinophilic Syndrome: Clinical, Molecular and Translational Aspects Jackson C, Sasankh AK, Arumugam NK, Raj SK, Ames E, Krishnaswamy G 2024 Jan 1 V1:323-V1:357 Relationship between tumor mutational burden, PD-L1, patient characteristics, and response to immune checkpoint inhibitors in head and neck squamous cell carcinoma Burcher KM, Lantz JW, Gavrila E, Abreu A, Burcher JT, Faucheux AT, Xie A, Jackson C, Song AH, Hughes RT, Lycan T, Bunch PM, Furdui CM, Topaloglu U, D’agostino RB, Zhang W, Porosnicu M Cancers 2021 Nov 13 Mastocytosis and mast cell activation disorders: Clearing the air Jackson CW, Pratt CM, Rupprecht CP, Pattanaik D, Krishnaswamy G International journal of molecular sciences 2021 Oct 22 Pruritic Rash in a Woman with Hodgkin Lymphoma Jackson C, Strowd L, Lamar Z JAMA Oncology 2019 Jun 5 900-901 Results 1-6 of 6 1
